Healthcare ❯ Pharmaceuticals ❯ Drug Pricing

Medicaid

Patient Access Direct-to-Consumer Sales Prescription Drugs Pfizer Healthcare Sector Performance Consumer Access Lower-Income Americans Access to Medicines Cost Reduction Health Equity Federal Regulations Biosimilars and Generics Most Favored Nation Pricing Consumer Impact Government Negotiations

AbbVie Strikes Trump Drug-Pricing Deal, Pledges $100 Billion, Wins 3-Year Tariff Reprieve

Opaque terms leave the real savings for patients, including Medicaid enrollees, uncertain.

Pfizer–Trump Drug-Pricing Deal and ‘TrumpRx’ Plan Jolt Health-Care Stocks Higher

Blog Jobs Terms of Service Privacy Policy Cookies Help Partners About Us Copyright © 2026 Mina Labs, Inc.

We value your privacy

We and our partners use cookies and similar technologies to understand how you use our site and to show you personalized advertisements on other platforms. By clicking "Accept All," you consent to these technologies for advertising, analytics and retargeting. Click "Decline All" to opt out of non-essential cookies. You can learn more in our Privacy Policy.